Showing results (81-90 of 651) with videos related to
Sort By:
Pageof 66
Journal of Diabetes and Its Complications|May 4, 2015
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetesBernt Johan von Scholten, Tine Willum Hansen, Jens Peter Goetze, et al.Diabetes Care|February 27, 2010
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsStine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, et al.Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.Diabetes, Obesity & Metabolism|September 29, 2020
Relationship between peripheral neuropathy, diastolic function and adverse cardiovascular outcome in individuals with type 1 diabetes mellitus without known cardiovascular disease: Results from the Thousand & 1 StudyGorm Mørk Hansen, Peter Godsk Jørgensen, Henrik Ullits Andersen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?Johannes F E Mann, Peter Rossing, Andrzej Wiȩcek, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2003
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathySteen Andersen, Peter Jacobsen, Lise Tarnow, et al.Journal of Market Access & Health Policy|August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect ComparisonDavid Cherney, Kerstin Folkerts, Paul Mernagh, et al.Diabetes Research and Clinical Practice|June 11, 2022
Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetesMostafa Safi, Anna Borup, Christian Stevns Hansen, et al.Nephron. Clinical Practice|December 17, 2010
Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up studyStine Elkjaer Nielsen, Henrik Post Hansen, Berit Ruud Jensen, et al.Proteomics. Clinical Applications|December 8, 2010
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapyKasper Rossing, Harald Mischak, Peter Rossing, et al.Pageof 66